These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34615581)

  • 21. Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):104-9. PubMed ID: 22236854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the GenoType MTBDR
    Lutchminarain K; Kajee A; Gandhi NR; Han KSS; Mvelase N
    Int J Tuberc Lung Dis; 2022 May; 26(5):426-432. PubMed ID: 35505490
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
    Chikamatsu K; Aono A; Yamada H; Mitarai S
    Kekkaku; 2012 Oct; 87(10):641-7. PubMed ID: 23214120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GenoType
    Theron G; Peter J; Richardson M; Warren R; Dheda K; Steingart KR
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010705. PubMed ID: 27605387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Evaluation of a Line-Probe Assay for Tuberculosis Detection and Drug-Resistance Prediction in Namibia.
    Günther G; Saathoff E; Rachow A; Ekandjo H; Diergaardt A; Marais N; Lange C; Nepolo E
    Microbiol Spectr; 2022 Jun; 10(3):e0025922. PubMed ID: 35670620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.
    Zeng X; Jing W; Zhang Y; Duan H; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):112-117. PubMed ID: 27345127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.
    Ajbani K; Nikam C; Kazi M; Gray C; Boehme C; Balan K; Shetty A; Rodrigues C
    PLoS One; 2012; 7(11):e49433. PubMed ID: 23166667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
    Huang WL; Chi TL; Wu MH; Jou R
    J Clin Microbiol; 2011 Jul; 49(7):2502-8. PubMed ID: 21562102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
    Barnard M; Warren R; Gey Van Pittius N; van Helden P; Bosman M; Streicher E; Coetzee G; O'Brien R
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1298-305. PubMed ID: 23087027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GenoType MTBDRsl performance on clinical samples with diverse genetic background.
    Miotto P; Cabibbe AM; Mantegani P; Borroni E; Fattorini L; Tortoli E; Migliori GB; Cirillo DM
    Eur Respir J; 2012 Sep; 40(3):690-8. PubMed ID: 22267773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robustness of the Line Probe Assay for the Rapid Diagnosis and Characterization of Mutations in Extensively Drug-Resistant Tuberculosis.
    Ninan MM; Rupali P; James P; Michael JS
    Microb Drug Resist; 2019; 25(6):799-804. PubMed ID: 30785833
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates.
    Kardan-Yamchi J; Amini S; Hamzelou G; Rahimi Foroushani A; Ghodousi A; Cirillo DM; Feizabadi MM
    Arch Microbiol; 2021 Sep; 203(7):3989-3996. PubMed ID: 34032874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic utility of GenoType MTBDR
    Yadav RN; Bhalla M; Kumar G; Sah GC; Dewan RK; Singhal R
    Int J Mycobacteriol; 2022; 11(2):183-189. PubMed ID: 35775551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China.
    Shi W; Davies Forsman L; Hu Y; Zheng X; Gao Y; Li X; Jiang W; Bruchfeld J; Diwan VK; Hoffner S; Xu B
    Int J Infect Dis; 2020 Jul; 96():390-397. PubMed ID: 32353546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.
    Singh AK; Maurya AK; Kant S; Umrao J; Kushwaha RA; Nag VL; Dhole TN
    J Postgrad Med; 2013; 59(3):179-85. PubMed ID: 24029194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MTBDRplus and MTBDRsl for simultaneous diagnosis of gastrointestinal tuberculosis and detection of first-line and second-line drug resistance.
    Sharma K; Sharma M; Sharma V; Sharma M; Parmar UPS; Samanta J; Sharma A; Kochhar R; Sinha SK
    J Gastroenterol Hepatol; 2023 Apr; 38(4):619-624. PubMed ID: 36652396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.
    Orikiriza P; Tibenderana B; Siedner MJ; Mueller Y; Byarugaba F; Moore CC; Evans EE; Bonnet M; Page AL; Bazira J; Boum Y
    PLoS One; 2015; 10(2):e0118191. PubMed ID: 25658921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl.
    Kaswa MK; Aloni M; Nkuku L; Bakoko B; Lebeke R; Nzita A; Muyembe JJ; de Jong BC; de Rijk P; Verhaegen J; Boelaert M; Ieven M; Van Deun A
    J Clin Microbiol; 2014 Aug; 52(8):2876-80. PubMed ID: 24871222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.